SCHEMBL27623587

SCHEMBL27623587

Cc1cc(OC(=O)NC(C)(C)C)c(C)cc1N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
GFER P55789 1/20 0.33
MAPT P10636 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
AAK1 Q2M2I8 1/20 0.32
ALDH1A1 P00352 1/20 0.32
RAB9A P51151 1/20 0.32
IMPDH2 P12268 1/20 0.31
IMPDH1 P20839 1/20 0.31
ACHE P22303 1/20 0.31
ALOX5 P09917 1/20 0.31
ADRB2 P07550 1/20 0.31
ADRB1 P08588 1/20 0.31
ADRB3 P13945 1/20 0.31
LMNA P02545 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27623452 0.94 CYP3A4 (0.36) CYP3A4TSHRMAPK1GAAMAPT
SCHEMBL27641583 0.80 CD44 (0.42) TSHRPOLBGAAMAPTRAB9A
SCHEMBL27543700 0.78 CFTR (0.39)
SCHEMBL27539550 0.78 GAA (0.33) MAPK1GAAMAPT
SCHEMBL27662009 0.78 CFTR (0.36) ADRB2LMNA
SCHEMBL28032033 0.76 ACHE (0.44) CYP3A4TSHRMAPTTDP1ALDH1A1
SCHEMBL4016329 0.76 TDP1 (0.42) CYP3A4MAPTTDP1ALDH1A1RAB9A
SCHEMBL27767915 0.76 ALDH1A1 (0.47) CYP3A4TDP1ALDH1A1RAB9AIMPDH2
SCHEMBL27767991 0.75 RAB9A (0.45) CYP3A4MAPK1MAPTAAK1ALDH1A1
SCHEMBL27761924 0.74 TSHR (0.38) CYP3A4TSHRIMPDH2IMPDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102584813-B Compound and the purposes in regulating amyloid beta thereof NGC药物公司 2016-07-06 CN disclosed
CN-102584813-A Compouds and uses thereof in modulating amyloid beta TORREYPINES THERAPEUTICS INC 2012-07-18 CN disclosed
CN-1787822-A Compounds and their use in modulating amyloid beta TORREYPINES THERAPEUTICS INC (US) 2006-06-14 CN disclosed